Latest news
Rallybio Corp (RLYB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 17:18:00 GMTRallybio Q2 2026: Financial Results, Risk Factors, and Avenzo Merger Insights - MinichartMinichart · Thu, 06 Aug 2026 22:48:00 GMTRallybio Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 19:06:38 GMTFMR LLC reports 15% Rallybio Corp (RLYB) stake, including 5% fund holding - Stock TitanStock Titan · Thu, 06 Aug 2026 14:49:11 GMTRallybio Corp 2Q 2026: Revenue $0 Net income $43.67M, EPS $7.53— 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 12:11:09 GMTRallybio (NASDAQ: RLYB) wins $50M fee, plans merger with Avenzo - Stock TitanStock Titan · Thu, 06 Aug 2026 12:03:47 GMTRLYB Stock Hits 2-Year Highs After Unveiling Merger With Avenzo – How Much Of The New Company Will Rallybio Shareholders Own? - stocktwits.comstocktwits.com · Wed, 05 Aug 2026 20:00:28 GMTLaurion Capital exits Rallybio (RLYB) position, reports 0% beneficial ownership - Stock TitanStock Titan · Tue, 04 Aug 2026 20:05:06 GMT